Merck & Co. has struck a $9.2 billion deal to buy biotechnology company Cidara Therapeutics in a move that bolsters the ...
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its ...
Following the FDA’s September announcement of a crackdown on direct-to | Monday, the FDA’s Office of Prescription Drug ...
Topline data from Phase 3 (IOB-013) clinical trial in advanced melanoma presented at ESMO; data highlights improvements in PFS achieved in overall population and across virtually all subgroups, althou ...
With the greater part of third quarter earnings results in the rearview mirror, investors are looking closely at marquee ...
ORLANDO, FL / ACCESS Newswire / November 14, 2025 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today congratulated its forme ...
Merck reported positive results from a trial of Winrevair, the heart drug that the company is counting on for much of its ...
If you've been spending time with Dispatch and feeling that Malevola's practically humming with early 1990s supermodel energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback